Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (181-190 of 407) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2003
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosisFred R Hirsch, Marileila Varella-Garcia, Paul A Bunn, et al.
Ugeskrift for Laeger|March 16, 2002
[Mammographic screening in the county of Copenhagen. Clinical consequences of the first three screening rounds]Ulla Brix Tange, Fred R Hirsch, Maj-Britt Jensen, et al.
Ugeskrift for Laeger|March 16, 2002
[Mammography screening in the county of Copenhagen. Results of the first three screening rounds]Ulla Brix Tange, Fred R Hirsch, Maj-Britt Jensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancerDaniel T Merrick, John Kittelson, Ralph Winterhalder, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics AssayPrimo N Lara, James Moon, Paul J Hesketh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2010
Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutationsYasufumi Kato, Nir Peled, Murry W Wynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapyFred R Hirsch, Roy S Herbst, Christine Olsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2009
Lung cancer in never smokers: molecular profiles and therapeutic implicationsCharles M Rudin, Erika Avila-Tang, Curtis C Harris, et al.
Cancer Research|July 19, 2002
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinomaMichio Sugita, Mark Geraci, Bifeng Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group StudyFred R Hirsch, Marileila Varella-Garcia, Jason McCoy, et al.
Pageof 41

Showing results (181-190 of 407) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2003
Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosisFred R Hirsch, Marileila Varella-Garcia, Paul A Bunn, et al.
Ugeskrift for Laeger|March 16, 2002
[Mammographic screening in the county of Copenhagen. Clinical consequences of the first three screening rounds]Ulla Brix Tange, Fred R Hirsch, Maj-Britt Jensen, et al.
Ugeskrift for Laeger|March 16, 2002
[Mammography screening in the county of Copenhagen. Results of the first three screening rounds]Ulla Brix Tange, Fred R Hirsch, Maj-Britt Jensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancerDaniel T Merrick, John Kittelson, Ralph Winterhalder, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics AssayPrimo N Lara, James Moon, Paul J Hesketh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2010
Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutationsYasufumi Kato, Nir Peled, Murry W Wynes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapyFred R Hirsch, Roy S Herbst, Christine Olsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2009
Lung cancer in never smokers: molecular profiles and therapeutic implicationsCharles M Rudin, Erika Avila-Tang, Curtis C Harris, et al.
Cancer Research|July 19, 2002
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinomaMichio Sugita, Mark Geraci, Bifeng Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group StudyFred R Hirsch, Marileila Varella-Garcia, Jason McCoy, et al.
Pageof 41